Hey Chris,
So far, so fun. Your info on Digene (DIGE) is interesting. Combining
a test for HPV with the the computerized scanner. Why did they
pick DIGE? Is their test cheaper or does it just happen to be
compatible with the scanner? Will DIGE be taken along for the ride
with CYTC?
I found out that the new marketing director was the director of new
product development and marketing at Abbot.(sp?). Since Abbot
has been doing well, I guess management picked someone who
has successfully brought new products to market (assuming the
guy deserves the credit).
The gyn's know of the competition but the fact is that the FDA for
some reason gave approval for CYTC to claim their test is better.
Maybe the test is better or maybe management sought out that
distinction for their machine for a marketting advantage. Anyway,
as long as Cytyc is the only one with FDA approval saying their
machine is much better than anything else out their, the window
of opportunity is open. The key now will be, can they get the
machines out there and will support be good enough to make long
term happy customers.
I usually don't like medical equipment manufacturers but lately
there are next generation technology companies coming out with
powerful and often CHEAPER tests. Check out IGEN in biomedical/
biotech under misc. You might have to search under Igen since
sometimes their hasn't been a recent post. I think it's an even more
compelling story with probably 1/2 billion in investments by their
partners. Real commitment. They have FDA approval and are
sold out in advance (300 shipped in Europe and they may have to
delay the US introduction till 1st quarter of 1997 because they are
placing all the analyzers they make,. The machine can detect
hundreds of biological substances faster, cheaper, and easier than
other tests. They have strong finances and good management.
There is no hype I'm aware of, so the price is cheap.
P.S., I'm still researching CYTC so my info will come in small boluses
as I find it out. You will see on the Igen posts that I know a lot more
about that company. Still, I did get 500 shares of CYTC based
entirely on the FDA approval news. As I learn more about CYTC, I
think that this might be another good one. The only thing missing
is a big committed partner that also has a lot at stake to help make
a new product a success.
Is it true that this company (CYTC) only has 3 million shares? If so,
do they have financial reserves to survive without more stock offering
until they make a profit? |
